MedPath

Phrixus Pharmaceuticals, Inc.

Phrixus Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Private
Established
2006-01-01
Employees
1
Market Cap
-
Website
http://www.phrixuspharmaceuticals.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Safety and Efficacy of P-188 NF in DMD Patients

Phase 2
Terminated
Conditions
Duchenne Muscular Dystrophy
Interventions
First Posted Date
2018-06-15
Last Posted Date
2023-01-11
Lead Sponsor
Phrixus Pharmaceuticals, Inc.
Target Recruit Count
2
Registration Number
NCT03558958
Locations
🇺🇸

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.